Longeveron Inc. Class A LGVN
NASDAQ · United States · Health Technology
$2.58-0.01 (-0.39%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -1.90 | -1.75 | -8.6% | $287.00K | -12.0% | +0.9%$6.92→$6.98 |
| Q1 2026 | 2026-05-13 | -1.90 | -1.72 | -10.5% | — | — | -6.3%$7.50→$7.03 |
| Q4 2025 | 2026-03-17 | -2.20 | -3.67 | +40.1% | — | — | +9.9%$8.88→$9.76 |
| Q3 2025 | 2025-11-04 | -3.90 | -2.57 | -51.8% | — | — | -8.3%$8.31→$7.62 |
| Q2 2025 | 2025-08-13 | -3.30 | -3.52 | +6.3% | — | — | — |
| Q1 2025 | 2025-05-08 | -3.40 | -3.27 | -4.0% | — | — | — |
| Q3 2024 | 2024-11-12 | -3.40 | -4.43 | +23.3% | — | — | — |
| Q2 2024 | 2024-08-14 | -18.30 | -8.70 | -110.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.